Current medical news and unique business news for anyone who cares about healthcare.
A revolution in microbiology. It’s being called a new age in microbiology by the New York Times, as technology now exists that allows experts to determine the entire genome sequence of microorganisms in hardly any time.
When the first bacterial genome was sequenced in 1995, it took 13 months and $1 million; today it takes just a few days and costs a little over $1,000. (Remember the $1,000 human genome?) Researchers say this makes it easier to map disease patterns and take better precautions against epidemics.
More stents and even more infections. In a time when there’s been much ado about heart stents, a new study adds fuel to the fire by concluding that the number of implantable heart devices has doubled since 1993, while the number of infections associated with them has more than tripled.
Medical apps: helpful or headache-inducing? A family doc sheds perspective on the pros and cons of medical mobile apps. And while we’re at it, here are ten predictions for the future of the mobile health industry.
Federal reform takes shape in state governments. From health insurance exchanges to rate regulation — how the states are impacting U.S. healthcare reform.
No for Novartis. The FDA declined to approve the Novartis drug for pain associated with gouty arthritis called canakinumab (Ilaris), instead requesting additional clinical data.